The RAS inhibitors such as angiotensin converting enzyme inhibitors (ACEIs) and angiotensin AT1-receptor blockers (ARBs) perform vascular protection by blocking the effects of angiotensin II [6], and/or by increasing the effects of bradykinin in the presence of DM. The gene discussed is AGT; the disease is diabetes mellitus.